mGluR4 PAM (Domain)
N/A
Report date: 2025/03/20 15:50:41
NME
Base Information
Drug NamemGluR4 PAM (Domain)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDomain Therapeutics SA
China Registration ClassN/A
Develop Information
Active CompaniesDomain Therapeutics SA
Inactive CompaniesMerck Serono Sa
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A